Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,453 | 15,566 | 10,571 | 50,404 | 221,036 |
| Marketable Securities | 231,380 | 265,223 | 279,913 | 248,747 | 88,835 |
| TOTAL | $268,617 | $283,773 | $293,242 | $302,969 | $310,545 |
| Non-Current Assets | |||||
| PPE Net | 1,439 | 912 | 911 | 524 | 499 |
| Other Non-Current Assets | 2,689 | 548 | 295 | 0 | 201 |
| TOTAL | $4,128 | $1,460 | $1,206 | $524 | $700 |
| Total Assets | $272,745 | $285,233 | $294,448 | $303,493 | $311,245 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,340 | 3,843 | 2,292 | 2,816 | 1,621 |
| TOTAL | $10,004 | $10,521 | $8,754 | $6,739 | $4,851 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,385 | 329 | 295 | 0 | 0 |
| TOTAL | $2,385 | $329 | $295 | $N/A | $N/A |
| Total Liabilities | $12,389 | $10,850 | $9,049 | $6,739 | $4,851 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,576 | 49,512 | 49,296 | 49,262 | 49,254 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -91,620 | -76,960 | -64,264 | -51,315 | -40,962 |
| Other shareholders' equity | -1,932 | -514 | -24 | -33 | -54 |
| TOTAL | $260,356 | $274,383 | $285,399 | $296,754 | $306,394 |
| Total Liabilities And Equity | $272,745 | $285,233 | $294,448 | $303,493 | $311,245 |